Top Hospitals in China
Book top-ranked medical institutions in China. Reference costs, not promises; we add zero markup to your hospital bill.
verified_user Independent patient coordination. Zero hospital markups. Not medical advice.
61 hospitals found
Chengdu First People's Hospital
Chengdu First People's Hospital was founded in 1896 and is one of Chengdu's long-established public Class A tertiary hospitals with strong overall clinical capabilities. The hospital has a solid specialty foundation in emergency and critical care, cardiovascular and cerebrovascular diseases, digestive diseases, orthopedics and minimally invasive surgery, geriatric medicine, and integrated oncology diagnosis and treatment. It continues to advance multidisciplinary care, same-day surgery, minimally invasive techniques, precision diagnosis and treatment, and smart hospital development. As one of the regional medical centers, its strengths include managing a large volume of complex and difficult cases, with relatively well-developed clinical pathways, emergency care systems, and comprehensive referral capabilities.
Chengdu Second People's Hospital
Chengdu Second People's Hospital is a long-established general hospital with strong clinical diagnosis and treatment capabilities, as well as regional medical service capacity. Because current online verification of the latest official public data is not available, the hospital's specialty strengths, technical capabilities, and operational indicators can only be conservatively entered as known historical information and items requiring verification. From the perspective of regional healthcare supply, it typically provides diagnosis and treatment for common and frequently occurring conditions, as well as some complex and severe cases. In specialty development, public Class A tertiary hospitals generally build comprehensive collaborative capabilities around emergency care, internal medicine, surgery, obstetrics and gynecology, pediatrics, critical care medicine, imaging, and laboratory testing. In terms of international competitiveness, if there is no publicly available information confirming an international medical center or multilingual outpatient services, it is more suitable for local and nearby patients rather than as a primary option for cross-border high-end medical care.
Chengdu Third People's Hospital
Chengdu Third People's Hospital is an important Class A tertiary general hospital in Chengdu. Its long-standing core strengths are in cardiovascular medicine, respiratory medicine, gastroenterology, urology, orthopedics, oncology-related care, and the treatment of acute and critical conditions, with strong multidisciplinary collaborative care capabilities. Within the public hospital system, it is known for comprehensive treatment, regional referral acceptance, and the management of complex and severe cases. It has well-developed capabilities in internal medicine, surgery, interventional procedures, minimally invasive treatment, and geriatric chronic disease management. Its technical strengths are mainly reflected in high-volume emergency care, MDT management of complex cases, minimally invasive surgery, and regional medical collaboration networks.
Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
Chengdu Hospital of Integrated Traditional Chinese and Western Medicine is a comprehensive hospital integrating medical care, teaching, research, rehabilitation, and preventive healthcare. It emphasizes integrated Traditional Chinese and Western medicine services, covering multidisciplinary collaborative treatment scenarios such as internal medicine, surgery, gynecology, orthopedics, acupuncture and tuina, and rehabilitation medicine. Its core strengths are typically reflected in the integrated management of chronic diseases, postoperative rehabilitation, pain treatment, sub-health management, and the comprehensive application of TCM特色外治法. It is suitable for patients who need long-term management and individualized treatment plans. As the latest publicly available operational and academic indicators cannot currently be verified online, the above core quantitative data are temporarily set to 0.
Chengdu BOE Hospital
Chengdu BOE Hospital is an important, high-level medical project in BOE Technology Group’s strategy for Southwest China, positioned as a modern comprehensive hospital integrating clinical care, health management, research and education, and smart hospital services. Because real-time external verification is currently unavailable in this round, it is not possible to reliably confirm its latest specialty structure, core technical capabilities, or key operational indicators such as outpatient, emergency, and surgical scale. If it will be used for serious decision-making, further verification through the hospital’s official website, publicly released information from the health commission, procurement records, and annual reports is recommended.
Nanjing Gulou Hospital
Nanjing Gulou Hospital (Affiliated Gulou Hospital of Nanjing University Medical School) was founded in 1892 and is one of the earliest Western-style hospitals established in China. It has long ranked among the country's leading large general Class A tertiary hospitals. The hospital is particularly strong in critical care medicine, cardiovascular medicine, respiratory and critical care medicine, gastroenterology, orthopedics, urology, obstetrics and gynecology, pediatrics, neurosurgery, and integrated cancer diagnosis and treatment. It has comprehensive capabilities in multidisciplinary care, treatment of complex and severe cases, minimally invasive and robotic surgery, and organ support and transplantation-related care. As a large teaching and research hospital, its strengths lie not only in high-volume clinical services, but also in well-developed subspecialty division, a mature MDT system, strong research translation capability, and multilingual services plus support from its International Medical Center for international patients.
Shanghai Proton and Heavy Ion Hospital
Shanghai Proton and Heavy Ion Hospital is the first tertiary oncology specialty hospital in mainland China to place proton and heavy ion radiotherapy at the core of its technology platform. It was established with investment from the Shanghai Shenkang Hospital Development Center and developed in collaboration with strong disciplinary resources such as Fudan University Shanghai Cancer Center. The hospital focuses on nasopharyngeal cancer, skull base tumors, central nervous system tumors, head and neck tumors, prostate cancer, lung cancer, liver cancer, pancreatic cancer, and selected recurrent or refractory solid tumors. It has built a diagnosis and treatment system centered on precision radiotherapy, multidisciplinary consultation, image guidance, individualized treatment planning, and full-process quality control. Its technical advantages mainly lie in the stronger biological effect of heavy ion high linear energy transfer, the normal tissue-sparing benefit of the Bragg peak dose distribution, and standardized treatment pathways and long-term follow-up databases developed for complex tumors. The hospital has a notable early-mover advantage in China’s advanced radiotherapy field and is one of the key institutions receiving cross-border cancer patients returning for treatment.
Fuwai Hospital, Chinese Academy of Medical Sciences
Fuwai Hospital, Chinese Academy of Medical Sciences (National Center for Cardiovascular Diseases), is the world's largest center for the diagnosis and treatment of cardiovascular diseases. The hospital holds a preeminent position in cardiovascular specialties and houses four national key laboratories. Its annual cardiac surgery volume has ranked first globally for consecutive years, with international acclaim for techniques in complex congenital heart disease, coronary artery bypass grafting (CABG), heart valve replacement, and heart transplantation. Through the National Center for Cardiovascular Diseases platform, the hospital integrates clinical research with translational medicine, establishing a comprehensive cardiovascular disease prevention and treatment system covering the entire life cycle.
Beijing Geriatric Hospital
Beijing Geriatric Hospital (formerly Beijing Chest Hospital established in 1949) is a municipal Class A tertiary general hospital and serves as the clinical research base for geriatric diseases for the Institute of Biophysics, Chinese Academy of Sciences. The hospital maintains significant clinical expertise in Comprehensive Geriatric Assessment (CGA), multidisciplinary management (MDT) of geriatric comorbidities, Alzheimer's disease care, geriatric rehabilitation, and palliative care. As a leader in geriatric medicine in China, the hospital has established a life-cycle care system aligned with international standards. It offers distinct advantages in reducing polypharmacy risks and shortening postoperative recovery cycles for elderly international patients, providing comprehensive health security for both domestic and international patients.
Peking University Shougang Hospital
Founded in 1949, Peking University Shougang Hospital is a large-scale Class A tertiary comprehensive hospital integrating medical care, education, research, and preventive medicine. As an affiliated hospital of Peking University, it maintains significant clinical expertise in gastrointestinal surgery, urology, orthopedics, and hospice care. The hospital established the first hospice care center within a tertiary hospital in China and has introduced advanced medical technologies, including single-port robotic surgical systems and TOMO helical tomotherapy. Furthermore, its 'Shougang Model' for cardiovascular chronic disease prevention and control has received recognition from the World Health Organization.